STOCK TITAN

Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Aziyo Biologics, Inc. (Nasdaq: AZYO) will release its third quarter 2022 financial results after market close on November 14, 2022. The company's management will host a conference call and webcast at 4:30 p.m. ET the same day. Investors can access the call via a designated link or by phone using the provided U.S. and international numbers. Aziyo specializes in regenerative medicine and offers a portfolio of commercial therapies aimed at enhancing surgical outcomes, particularly in implantable medical devices.

Positive
  • Upcoming financial results likely indicate progress in business developments.
Negative
  • None.

SILVER SPRING, Md., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company with a portfolio of commercial therapies, today announced that it will release third quarter 2022 financial results after market close on Monday, November 14, 2022. Members of the Company’s management team will host a conference call and webcast with accompanying slides starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 866-682-6100
International Investors: 862-298-0702
Conference ID: 13734285

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Aziyo website at https://investors.aziyo.com/.

About Aziyo Biologics
Aziyo Biologics is a regenerative medicine company with a commercial portfolio of differentiated products focused on improving outcomes in patients undergoing a range of surgical procedures, primarily for implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.

Investors:
Matt Ferguson
Aziyo Biologics, Inc.
investors@aziyo.com 

Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com 


FAQ

When will Aziyo Biologics announce its third quarter 2022 financial results?

Aziyo Biologics will announce its third quarter 2022 financial results after market close on November 14, 2022.

What time will the Aziyo Biologics conference call take place?

The conference call for Aziyo Biologics will start at 4:30 p.m. ET on November 14, 2022.

How can I access the Aziyo Biologics financial results conference call?

The conference call can be accessed via a webcast link or by calling the U.S. number 866-682-6100 or the international number 862-298-0702.

What is the focus of Aziyo Biologics' products?

Aziyo Biologics focuses on regenerative medicine and offers products aimed at improving outcomes in surgical procedures involving implantable medical devices.

Elutia Inc.

:AZYO

AZYO Rankings

AZYO Latest News

AZYO Stock Data

24.21M
4.12M
2.18%
70.44%
0.42%
Medical Devices
Healthcare
Link
United States
Silver Spring